Home IntelGenx

IntelGenx

In operation
Post-IPO Round
Drug Development and Service Provider

Basic Information

IntelGenx is a drug delivery company focused on the development of oral controlled-release products and novel fast-dissolving delivery systems. IntelGenx utilizes its proprietary multi-layer delivery system to achieve zero-order release of active pharmaceutical ingredients in the gastrointestinal tract. Based on its expertise in fast-dissolving films, IntelGenx has also developed new delivery technologies for the rapid administration of active pharmaceutical ingredients in the oral cavity. IntelGenx's R&D pipeline includes products for the treatment of pain, hypertension, osteoarthritis, and depression.
IntelGenx Corp.
Quebec,Canada
15~50 people
January 01, 2003
Info@Intelgenx.Com